Neutralizing HIV Antibodies

Several methods have been utilized to isolate and characterize individual antibodies from the human repertoire and each of these methods has been applied to the generation of broadly neutralizing HIV antibodies. Discover the latest research on neutralizing HIV antibodies.

December 7, 2021
Open Access

Higher mucosal antibody concentrations in women with genital tract inflammation.

Scientific Reports
Parveen SobiaDerseree Archary
December 7, 2021

Immunotherapeutic approaches to HIV cure and remission.

Current Opinion in Infectious Diseases
Ming J LeeJohn Frater
December 6, 2021

Association Between Ov16 Seropositivity and Neurocognitive Performance Among Children in Rural Cameroon: a Pilot Study.

Journal of Pediatric Neuropsychology
Joseph Nelson Siewe FodjoAlfred K Njamnshi
December 6, 2021
Open Access

Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121.

Frontiers in Immunology
Wen Shi LeeStephen J Kent
December 6, 2021
Case Report

Talaromyces Marneffei Infection in Lung Cancer Patients with Positive AIGAs: A Rare Case Report.

Infection and Drug Resistance
Fanhai LinJianquan Zhang
December 5, 2021
Open Access

Design of an optimal combination therapy with broadly neutralizing antibodies to suppress HIV-1

MedRxiv : the Preprint Server for Health Sciences
Colin LaMontArmita Nourmohammad
December 4, 2021
Open Access

Altered Lipid Profiles and Vaccine Induced-Humoral Responses in Children Living With HIV on Antiretroviral Therapy in Tanzania.

Frontiers in Cellular and Infection Microbiology
Wilbert MbuyaMkunde Chachage
December 4, 2021
Open Access

Are HIV-1-Specific Antibody Levels Potentially Useful Laboratory Markers to Estimate HIV Reservoir Size? A Review.

Frontiers in Immunology
Silvere D ZaongoYaokai Chen
December 3, 2021
Open Access

HIV care coverage among HIV-positive adolescent girls and young women in South Africa: Results from the HERStory Study.

South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
C MathewsG Gray
December 2, 2021

Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021.

Nature Medicine
Steven G DeeksInternational AIDS Society (IAS) Global Scientific Strategy working group
December 2, 2021

Current status of hepatitis C virus among people living with human immunodeficiency virus in Egypt.

Transactions of the Royal Society of Tropical Medicine and Hygiene
Aisha ElsharkawyGamal Esmat
November 30, 2021
Open Access

Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials.

PLoS Pathogens
Stephanie FischingerGalit Alter

Sign up to follow this feed and discover related papers.

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.


Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.


Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Astrocytes in Repair & Regeneration

Astrocytes are glial cells found within the CNS and are able to regenerate new neurons. They become activated during CNS injury and disease. The activation leads to the transcription of new genes and the repair and regeneration of neurons. Discover the latest research on astrocytes in repair and regeneration here.

© 2021 Meta ULC. All rights reserved